TELA Bio, Inc.
TELA
$1.30
-$0.02-1.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.52% | 11.55% | 3.83% | 25.94% | 11.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.52% | 11.55% | 3.83% | 25.94% | 11.02% |
| Cost of Revenue | 21.82% | 14.33% | 19.97% | 31.44% | 17.27% |
| Gross Profit | 27.15% | 10.29% | -3.44% | 23.55% | 8.47% |
| SG&A Expenses | 3.26% | -4.24% | -17.30% | 10.73% | 12.58% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.85% | -0.06% | -11.18% | 12.24% | 11.29% |
| Operating Income | 21.51% | 15.59% | 31.96% | 8.01% | -11.66% |
| Income Before Tax | 21.51% | -98.06% | 27.45% | 5.34% | -16.77% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 21.25% | -98.98% | 28.56% | 5.34% | -16.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.25% | -98.98% | 28.56% | 5.34% | -16.77% |
| EBIT | 21.51% | 15.59% | 31.96% | 8.01% | -11.66% |
| EBITDA | 22.17% | 16.16% | 33.25% | 8.64% | -11.56% |
| EPS Basic | 57.19% | -8.03% | 56.34% | 6.17% | -10.04% |
| Normalized Basic EPS | 57.31% | 54.02% | 55.65% | 6.19% | -10.03% |
| EPS Diluted | 57.19% | -8.03% | 56.34% | 6.17% | -10.04% |
| Normalized Diluted EPS | 57.31% | 54.02% | 55.65% | 6.19% | -10.03% |
| Average Basic Shares Outstanding | 83.94% | 84.17% | 63.64% | 0.90% | 6.13% |
| Average Diluted Shares Outstanding | 83.94% | 84.17% | 63.64% | 0.90% | 6.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |